<DOC>
	<DOCNO>NCT00529269</DOCNO>
	<brief_summary>This study evaluate impact GI complaints patient-reported outcome determine improvement patient-reported outcome convert mycophenolate mofetil ( MMF ) Enteric-coated mycophenolate sodium ( EC-MPS )</brief_summary>
	<brief_title>Measurement Patient Reported Outcomes Korean Renal Transplant Patients With Without Gastrointestinal ( GI ) Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Received kidney transplant least 1 month prior study enrollment Receiving immunosuppressive regimen include MMF least 2 week prior study enrollment Eligible convert entericcoated mycophenolate sodium ( ECMPS ) GI complaint OR currently experience GI complaint stable current immunosuppressive regimen At least 18 year age Willing provide write informed consent Able meet study requirement include complete electronicallyadministered questionnaire complete two study visit . GI symptom assume know caused MPA ( Mycophenolic acid ) therapy ( e.g . oral biphosphonates induce , infectious diarrhea ) Acute rejection &lt; 1 week prior study enrollment Woman childbearing potential planning become pregnant pregnant and/or lactate unwilling use effective mean contraception Presence psychiatric illness ( i.e. , schizophrenia , major depression ) , opinion site investigator , would interfere study requirement ; Undergoing acute medical intervention hospitalization Any medical condition , opinion site investigator base recall chart review , would interfere complete study , include limited , visual problem cognitive impairment Receiving investigational drug receive investigational drug within 30 day prior study enrollment . Other protocoldefined inclusion /exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Renal Transplant Patients , GI symptom , Enteric-coated mycophenolate sodium</keyword>
</DOC>